GlaxoSmithKline
Is this an opportunity to take a position ahead of the results?
GlaxoSmithKline reports results on Wednesday, 31 October
- The chart shows the price movement last time GlaxoSmithKline reported: H1 Results, 25 Sept.
- Shares opened +5p (+0.3%), went as low as -16.4p (-1.1%) and as high as +41p (+2.6%).
- The shares closed -14.4p (-0.9%) for a daily range of 57.4p or 3.7%.
- Shares -7.1% from 2018 highs; +22.1% from 2018 lows; +15.7% year-to-date.
- Recent share price range: Oct lows 1429p; Oct highs 1563p. Currently 1530p (at time of writing).
- GlaxoSmithKline publishes Q3 Results on Wednesday, 31 Oct.
- Will we see another big move?
- Source: Bloomberg, FT, Reuters, DJ Newswires
Trading GlaxoSmithKline – An Example
Let’s say you think that GlaxoSmithKline results are likely to be good, and the share price is likely to rise. You decide to buy exposure to £10,000 worth of GlaxoSmithKline using CFDs, at the current price of 1529p. To do this, you need £2,000.
For the purpose of this example, let’s assume GlaxoSmithKline reports strong results and the shares rise 10%. Your profit would be £1,000, from your initial investment of £2,000.
Conversely, let’s assume you open the position, and place a stop-loss 5% below the current price. GlaxoSmithKline results miss, it falls 5% and hits your stop-loss. Your loss would be £500.
This is provided for information purposes only. It should not be taken as a recommendation.